Research Trends on the Efficacy of Antidepressant Medications in Adults with Major Depressive Disorder

Major Depressive Disorder (MDD) is a prevalent psychiatric condition characterized by significant emotional and functional impairments. This review aims to examine recent research on the efficacy of antidepressant medications in adults, focusing on drug classes such as SSRIs, SNRIs, TCAs, MAOIs, and novel agents like ketamine. It synthesizes findings from meta-analyses, pharmacogenetic studies, and advancements in neuroimaging, highlighting a shift toward personalized psychiatry. An evidence-based intervention protocol is proposed, integrating pharmacotherapy with psychotherapeutic approaches, including CBT, ACT, and IPT. Despite advancements, challenges persist in treatment accessibility, resistance, and long-term efficacy. The review advocates for integrated, patient-centered models addressing both biological mechanisms and systemic barriers to optimize MDD management.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-31
DOI
https://doi.org/10.5281/zenodo.17356386
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research Trends on the Efficacy of Antidepressant Medications in Adults with Major Depressive Disorder

Zenodo (CERN European Organization for Nuclear Research)
Treatment of Major Depression
article

Research Trends on the Efficacy of Antidepressant Medications in Adults with Major Depressive Disorder

article en

Abstract

Major Depressive Disorder (MDD) is a prevalent psychiatric condition characterized by significant emotional and functional impairments. This review aims to examine recent research on the efficacy of antidepressant medications in adults, focusing on drug classes such as SSRIs, SNRIs, TCAs, MAOIs, and novel agents like ketamine. It synthesizes findings from meta-analyses, pharmacogenetic studies, and advancements in neuroimaging, highlighting a shift toward personalized psychiatry. An evidence-based intervention protocol is proposed, integrating pharmacotherapy with psychotherapeutic approaches, including CBT, ACT, and IPT. Despite advancements, challenges persist in treatment accessibility, resistance, and long-term efficacy. The review advocates for integrated, patient-centered models addressing both biological mechanisms and systemic barriers to optimize MDD management.

Zenodo (CERN European Organization for Nuclear Research)
Health Awareness (United States) (US)
Good health and well-being
Openalex Percentile: Top 38%
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Research Trends on the Efficacy of Antidepressant Medications in Adults with Major Depressive Disorder · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS